Journal of Integrative Health Research

VOLUME 3 , ISSUE 1 ( January-June, 2026 ) > List of Articles

ORIGINAL RESEARCH

Study of Immunological Markers in Clinically Suspected Cases of Dengue

Anjaliben Rajubhai Patel, Vaishnavi M Patel

Keywords : Dengue, IgG, IgM, NS1 antigen, Retrospective, Serological markers, Serology

Citation Information : Patel AR, Patel VM. Study of Immunological Markers in Clinically Suspected Cases of Dengue. 2026; 3 (1):5-8.

DOI: 10.5005/jihr-11055-0034

License: CC BY-NC 4.0

Published Online: 30-06-2026

Copyright Statement:  Copyright © 2026; The Author(s).


Abstract

Dengue virus is transmitted by mosquitoes and represents a major public health problem in tropical and subtropical regions of the world. Early diagnosis is essential for appropriate patient management and prevention of complications. Aim of the study: The main objective was to assess the distribution of dengue immunological markers [NS1 antigen, immunoglobulin M (IgM) antibody, and immunoglobulin G (IgG) antibody] among clinically suspected dengue patients and to correlate these findings with thrombocytopenia. Materials and methods: The present study was a retrospective descriptive study that involved 352 serum samples from clinically suspected dengue patients. NS1 antigen and antibody (IgM, IgG) levels were measured using an immunochromatography (ICT) test for NS1. Results: Out of 352 samples, 109 (30.96%) were seropositive for at least one dengue serological marker. NS1 antigen was detected in 42 (38.53%) cases, IgM antibody in 28 (25.68%) cases, and IgG antibody in 9 (8.25%) cases. Multiple-marker positivity was observed in 30 (27.54%) cases, including combinations of NS1 + IgM, IgM + IgG, and NS1 + IgM + IgG. Thrombocytopenia was the most prominent hematological finding and was observed more frequently among seropositive patients than seronegative patients. Conclusion: NS1 antigen, IgM, and IgG antibodies are important markers for the laboratory diagnosis of dengue infection. NS1 antigen helps with early detection during the acute phase, while IgM indicates recent infection and IgG suggests past exposure. The combined use of these markers improves diagnostic accuracy and helps determine the stage of disease.


HTML PDF Share
PDF Share
  1. Bhatt S, Gething PW, Brady OJ, et al. The global distribution and burden of dengue. Nature 2013;496(7446):504–507. DOI: 10.1038/nature12060
  2. Schaefer TJ, Panda PK, Wolford RW. Dengue fever. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430732/
  3. Murray NE, Quam MB, Wilder-Smith A. Epidemiology of dengue: past, present and future prospects. Clin Epidemiol 2013;5:299–309. DOI: 10.2147/CLEP.S34440
  4. Edeling MA, Diamond MS, Fremont DH. Structural basis of flavivirus NS1 assembly and antibody recognition. Proc Natl Acad Sci U S A 2014;111(11):4285–4290. DOI: 10.1073/pnas.1322036111
  5. Kuo HJ, Lee IK, Liu JW, et al. Analyses of clinical and laboratory characteristics of dengue adults at their hospital presentations based on the World Health Organization clinical-phase framework: emphasizing risk of severe dengue in the elderly. J Microbiol Immunol Infect 2018;51:740–748. DOI: 10.1016/j.jmii.2016.08.024
  6. World Health Organization. Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control, 2nd edition. Geneva: World Health Organization; 1997.
  7. Kalayanarooj S. Clinical manifestations and management of dengue/DHF/DSS. Trop Med Health 2011;39(4 Suppl.):83–87. DOI: 10.2149/tmh.2011-S10
  8. Khor YS, Sam SS, Tong KL, et al. Evaluation of immune-endothelial activation markers for the differentiation of severe dengue.J Transl Med 2025;24(1):93. DOI: 10.1186/s12967-025-07521-z
  9. Alcon S, Talarmin A, Debruyne M, et al. Enzyme-linked immunosorbent assay specific to dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J Clin Microbiol 2002;40(2):376–381. DOI: 10.1128/JCM.40.02.376-381.2002
  10. Ur Rahman M, Tabassum S, Salman M, et al. Clinical and laboratory markers of acute dengue infection. Ann Abbasi Shaheed Hosp Karachi Med Dent Coll 2024;29(3):283–290. DOI: 10.58397/ashkmdc.v29i3.882
  11. Thergarajan G, Sekaran SD. Diagnostic approaches for dengue infection. Expert Rev Mol Diagn 2023;23(8):643–651. DOI: 10.1080/14737159.2023.2234815
  12. Guzman MG, Kouri G. Dengue diagnosis, advances and challenges. Int J Infect Dis 2004;8(2):69–80. DOI: 10.1016/j.ijid.2003.03.003
  13. Vaughn DW, Nisalak A, Solomon T, et al. Rapid serologic diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary infections. Am J Trop Med Hyg 1999;60(4):693–698. DOI: 10.4269/ajtmh.1999.60.693
  14. Velu V, Manivel A, Sabastin M, et al. Assessment of expression of TNF signaling proteins in dengue cases as potential biomarkers for predicting severity of the disease in the study population. Microb Pathog 2025;206:107688. DOI: 10.1016/j.micpath.2025.107688
  15. Mukherjee S, Saha B, Tripathi A. Clinical significance of differential serum-signatures for early prediction of severe dengue among Eastern Indian patients. Clin Exp Immunol 2022;208(1):72–82. DOI: 10.1093/cei/uxac018
  16. Pereira SH, Franco-Luiz APM, Nogueira CT, et al. Clinical, serological, and molecular profile of dengue patients with warning signs during the 2024 outbreak in Belo Horizonte, Brazil. J Med Virol 2026;98(1):e70805. DOI: 10.1002/jmv.70805
PDF Share
PDF Share

© 2026. Jaypee Brothers Medical Publishers (P) Ltd. | All Rights Reserved.